Skip to main content
. 2020 Apr 30;26(2):180–203. doi: 10.5056/jnm20014

Table 1.

Levels of Evidence and Support for the Various Primary Esophageal Achalasia Treatment Recommendations4

Level of evidence
High At least one RCT or SR/meta-analysis with no concern regarding study quality
Moderate At least one RCT or SR/meta-analysis with minor concerns regarding study quality or, at least one cohort/case-control/diagnostic test design study with no concern regarding study quality
Low At least one cohort/case-control/diagnostic test study with minor concerns regarding study quality, or at least one single arm before-after study or, cross-sectional study with no concerns regarding study quality
Very low At least one cohort/case-control/diagnostic test design study with serious concerns regarding study quality, or at least one single arm before-after study or cross-sectional study with minor/severe concerns regarding study quality

Grade of recommendation

Strong for The benefits of the intervention are greater than the harms based on a high or moderate level of evidence, such that it can be strongly recommended for clinical practice in most cases.
Weak for The benefits and harms of the intervention may vary depending on the clinical situation or patient characteristics. Recommended depending to the clinical situation.
Weak against The benefits and harms of the intervention may vary depending on the clinical situation or patient characteristics. Intervention not be recommended for clinical practice.
Strong against The harms of the intervention are greater than the benefits based on a high or moderate level of evidence, such that it is not recommended for clinical practice.
No recommendation It is not possible to classify the recommendation owing to a lack of evidence or equivocal results. Further evidence is needed.

RCT, randomized controlled trial; SR, systematic review.